Report error Found 31 Enz. Inhib. hit(s) with all data for entry = 50040987
Affinity DataIC50: 20nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 60nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 60nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 60nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 130nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 180nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 180nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 190nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 190nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 520nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 580nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 1.40E+3nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+3nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+3nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 5.20E+3nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 6.00E+3nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 6.50E+3nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 9.00E+3nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+4nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair
Affinity DataIC50: 2.60E+4nMAssay Description:Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619More data for this Ligand-Target Pair






























